2022 Annual Dinner Meeting & Celebration Program Book

www.BioNJ.org



Because Patients Can’t Wait® Because Patients Can’t Wait®

Welcome to BioNJ’s 29th Annual Dinner Meeting and
Innovation Celebration honoring the exceptional medical
innovation coming from New Jersey. Because Patients
Can’t Wait®, tonight’s program is dedicated to the
Garden State’s robust life sciences ecosystem where we
are working together to bring new therapies and cures to
those in need.
Our industry is changing the future for Patients around the world. And, having been two
years since our last Annual Dinner Meeting, we have a lot to celebrate!
New Jersey remains a leading innovation powerhouse – with nearly 40% of all FDA
drug approvals in 2020 and 2021 coming from companies with a footprint right here
at home, including the first COVID-19 vaccines, saliva test and therapeutics. Tonight, we
will honor these companies with an Innovator Award and pay tribute to our New Jersey
COVID-19 Heroes by presenting them with a beloved Heart of BioNJ Award.
We are pleased to have Dr. Sol J. Barer present the 14th Annual Dr. Sol J. Barer
Award for Vision, Innovation and Leadership to the Honorable Judith M. Persichilli
for her tireless work on behalf of Patients, leading the State’s response to the COVID-19
pandemic and improving New Jersey’s health care system.
Our ecosystem continues to flourish and grow as evidenced by the recent
groundbreaking at The Hub in New Brunswick and the launch of The Cove in Jersey
City to the numerous ribbon cuttings of new headquarters and facilities of biopharma
companies expanding in or moving to the Garden State.
Tonight we raise our glasses in honor of all these accomplishments. As always at BioNJ,
we have many people to thank for their generosity, dedication and contributions to
making this meeting possible. We are indebted to our Board of Trustees, our Annual
Dinner Meeting Committee, chaired by Darek Hahn of Cerberus Sentinel and Bill
DeStafano of Marsh Inc., our generous Sponsors, New Jersey’s vibrant life sciences
ecosystem and our dedicated BioNJ Team.
Thank you all for being here.
Because Patients Can’t Wait®,

William H. Lewis, JD, MBA Debbie Hart

Chairman of the Board President & Chief Executive Officer

BioNJ BioNJ
Chair and CEO
Insmed

1

2022 BioNJ Board of Trustees

CHAIR Novartis Services, Inc. INVESTOR ADVISOR
Will Lewis, JD, MBA Susan L. Levinson, Ph.D. George Heinrich, M.D.
Chair & CEO CEO Vice Chair & CEO
Insmed, Inc. BioAegis Therapeutics, Inc. New Jersey Health Foundation, Inc.,
& Foundation Venture Capital Group,
PRESIDENT & CHIEF John Maki LLC (FVCG)
EXECUTIVE OFFICER CEO
Debbie Hart Bayesian Biotech LEGAL ADVISOR
BioNJ Emilio Ragosa
Anthony S. Marucci, MBA Partner & Managing Partner, Short
IMMEDIATE PAST CHAIR Founder, President, CEO & Director Hills Office
Christopher J. Schaber, Ph.D. Celldex Therapeutics, Inc. DLA Piper
President & CEO
Soligenix, Inc. Scott Megaffin STATE GOVERNMENT OFFICIAL
President & CEO ADVISOR
TREASURER Adiso Therapeutics Kathleen Coviello
Jeffrey A. Nau, Ph.D., MMS Executive Vice President for
President & CEO Christopher Mortko, Ph.D., MBA Technology, Life Sciences &
Oyster Point Pharma, Inc. Associate Vice President, Head of HQ Entrepreneurship
Search & Evaluation New Jersey Economic Development
SECRETARY Merck Business Development & Authority (NJEDA)
Michele Korfin, R.Ph., MBA Licensing
Chief Operating Officer & TECHNOLOGY ADVISOR
Chief Commercial Officer Andrew L. Pecora, M.D., FACP, CPE Anu Gupta
Gamida Cell Chairman, Outcomes Matter Senior Partner, Global Leader,
Innovations, LLC Enterprise Strategy
BOARD MEMBERS President, Celularity IBM Healthcare & LifeSciences
Sol J. Barer, Ph.D.
Former Chairman & Chief Stuart W. Peltz, Ph.D. Teresa Leste
Executive Officer CEO Principal, Life Sciences Strategy &
Celgene Corporation PTC Therapeutics, Inc. Analytics
Chairman of the Board Deloitte
Teva Pharmaceutical Industries Spiro Rombotis, MPH, MBA
President & CEO Gregory Oakes, MBA
Carrie Brown Cyclacel Pharmaceuticals, Inc.
Head, U.S. Communications & CSR James Sapirstein, R.Ph., MBA
Sanofi Bob Smith President, Chairman, and CEO
Senior Vice President, Global First Wave BioPharma
Amadou Diarra Gene Therapy Business and Early
Senior Vice President, Global Policy, Commercial Development, Rare Brian Wilcomes
Advocacy & Government Affairs Disease Business Unit, Pfizer Strategy & Analytics Principal
Bristol Myers Squibb Biopharmaceuticals Group Deloitte & Touche LLP
Pfizer Inc.
Jayne C. Gershkowitz
Chief Patient Advocate Marco Taglietti, M.D.
Amicus Therapeutics, Inc. President & CEO
SCYNEXIS, Inc.
David Jiménez
President, Janssen Immunology BOARD ADVISORS
Janssen Pharmaceutical Companies of
Johnson & Johnson ACADEMIC ADVISOR
Reynold A. Panettieri, Jr., M.D.
Christian Kopfli, Esq. Professor of Medicine, Robert Wood
CEO Johnson Medical School
Chromocell Corporation Vice Chancellor, Clinical & Translational
Science
Emer Leahy, Ph.D. Director, Rutgers Institute for
President & CEO Translational Medicine & Science
PsychoGenics, Inc. Emeritus Professor of Medicine,
University of Pennsylvania
Leigh Anne Leas Rutgers, The State University of New
Vice President & Head, Jersey
North America Public Policy

2

2022 Annual Dinner Meeting Committee Members

Bill DeStefano Co-Chair Maxson Jareki
Marsh Inc. Psychogenics
Darek Hahn Co-Chair
Cereberus Sentinel Andrew Latham, Ph.D.
Angie Bechan Merck
Sanofi
James Bruno, MBA Jack Levitt, MBA, EMTM
Chemical & Pharmaceutical Solutions LeaderStrong
John Cahill
Jones Lang LaSalle Marisol Mendez Peron
Marshall Calman Genmab
MBA, PCC,LeaderStrong
Richard Clements Wyman Morgan
WhizAI Infinity Resources LLC
Mandy Fahey
Insmed Chris Schaber, Ph.D.
Nikki Frazier Soligenix, Inc.
Centri Business Consulting
Jayne Gershkowitz Judith Sheft, MBA, MSc
Amicus Therapeutics, Inc. New Jersey Commission on Science, Innovation
Ethan Hasbrouck and Technology
Bristol Myers Squibb
Tracy Henrikson, MBA Ebony Staton Weidman
Eli Lilly and Company Janssen Pharmaceuticals
Paul Howard, JD
Amicus Therapeutics, Inc. Tony Torrington, CPA
Ernst & Young

Joel Wagner, CPA
Ernst & Young

Jordan Warshafsky, MBA
Ashton Tweed, LTD.

Brian Wilcomes, CPA
Deloitte

BioNJ TEAM Katina Pearl-Blando
Project Manager
Debbie Hart [email protected]
President & CEO
[email protected] Dawn Piccioni
Marketing Manager
Samantha Bamberger [email protected]
Director, BioPartnering Conference & Committees
[email protected] Cheri Potts
Office Manager
Randi Bromberg [email protected]
Vice President, Communications
and Marketing Dana Sacco
[email protected] Executive Assistant
[email protected]
Donna Gibbons
Senior Vice President, Operations Peggy Schell
[email protected] Talent Services and Public Policy
Assistant
Denise Machado [email protected]
Membership Operations Manager
[email protected] Ann Wieczkowski
Accounting Services Manager
Debbie Mennito [email protected]
Director, Talent Services & Events
[email protected]

Kim Minton
Director, Member Engagement
[email protected]

3

Thank You to Our Sponsors

HEART OF BioNJ AWARD SPONSORS
Bristol Myers Squibb ♦ Thermo Fisher Scientific ♦ Pfizer

Teva Pharmaceutical Industries

TABLE SPONSORS
ADC Therapeutics ♦ Amicus Therapeutics
Biotechnology Innovation Organization Bristol Myers Squibb ♦ Conner Strong
♦ Deloitte ♦ DLA Piper ♦ Endo Pharmaceuticals ♦ EY ♦ Faegre Drinker
Genmab ♦ Gilead Sciences, Inc. ♦ Helsinn ♦ Infinity Biologix ♦ Insmed
Janssen ♦ Keiretsu Forum ♦ Eli Lilly & Company ♦ Marsh
McKinsey & Company ♦ Melinta ♦ Merck & Co. ♦ Morgan Stanley ♦ New
Jersey Health Foundation ♦ New Jersey Institute of Technology (NJIT)
Novartis ♦ NS Pharma ♦ Oyster Point ♦ Princeton University ♦ PTC
Therapeutics ♦ RSM ♦ Rutgers Biomedical & Health Sciences-RUF ♦ Sanofi
Stone Creek Construction ♦ Taiho Oncology ♦ Thermo Fisher Scientific
USI Insurance ♦ Venable LLP ♦ Vifor Pharma Group

4

COCKTAIL SPONSORS
Adare Pharma Solutions ♦ Centi Business Consulting ♦ Friedman LLP
Incedo, Inc. ♦ New Jersey Manufacturing Extension Program (NJMEP)

PsychoGenics ♦ We Work for Health

DESSERT SPONSORS
Ascendia Pharma ♦ Ashton Tweed ♦ EisnerAmper ♦ PHL Life Sciences

Soligenix, Inc. ♦ WhizAI

MEDIA SPONSORS
NJBiz ♦ NJ Business Magazine

VIDEO SPONSOR
Pulse Productions

Tweet about BioNJ’s Annual Dinner Meeting
and Innovation Celebration!

#PatientsCantWait

5

THE BOARD OF TRUSTEES OF
BioNJ WELCOMES YOU TO THE
2022 ANNUAL DINNER MEETING,
NETWORKING EVENT AND INNOVATION CELEBRATION

June 9, 2022

Hilton East Brunswick

4:45 p.m. – 5:50 p.m.

Networking Reception

6:00 p.m. – 8:30 p.m.

Dinner Program Networking and Awards Ceremony

OPENING CEREMONIES

Welcome
Debbie Hart
President and CEO, BioNJ

Remarks
Senate President Steve Sweeney
Third Legislative District, New Jersey

6

Saluting Innovators and
the Patients Who Inspire Them

♦ INNOVATOR AWARDS ♦

Presented by
Minister Mary Phillips-Blackshear and Jean Walters

♦ DINNER AND NETWORKING ♦
THE DR. SOL J. BARER AWARD FOR VISION,

INNOVATION AND LEADERSHIP

Presented by
Sol J. Barer, Ph.D.
Former Chairman and CEO, Celgene Corporation and
Chairman of the Board, Teva Pharmaceutical Industries

to
Honorable Judith M. Persichilli

♦ HEART OF BioNJ AWARDS ♦

Presented to
New Jersey COVID-19 Heroes

Presented by
Christopher J. Schaber, Ph.D.,
Immediate Past Chair, BioNJ and President and CEO, Soligenix, Inc.

Closing
Debbie Hart
DESSERT AND NETWORKING RECEPTION

7

Innovator Awards
Honoring 2020 & 2021 FDA Approvals

• AbbVie for Durysta™, Oriahnn®, Qulipta™ and Vuity™
• ADC Therapeutics for Zynlonta®
• Agile Therapeutics for Twirla®
• Althera Pharmaceuticals for Roszet®
• Ascendis Pharma for Skytrofa®
• Athenex for Klisyri®
• Bayer for Kerendia® and Lampit®
• Boehringer Ingelheim for Trijardy® XR
• Bristol Myers Squibb for Abecma®, Breyanzi®, Onureg® and Zeposia®
• Calliditas Therapeutics for Tarpeyo™
• Dr. Reddy’s for Elyxyb™ and Xeglyze™
• Edenbridge Pharmaceuticals for Dartisla ODT
• Eli Lilly and Company for Lyumjev®, Retevmo®, Tauvid™ and Trijardy® XR
• Endo International for Qwo®
• Genmab for Tivdak™
• Gilead Sciences Trodelvy® and Veklury®
• GSK for Blenrep and Jemperli
• Helsinn Healthcare for Truselgiq®
• Hikma Pharmaceuticals for Kloxxado™
• Janssen Pharmaceutical Companies of Johnson & Johnson for Ponvory™ and

Rybrevant®

• LEO Pharma for Adbry™
• Melinta Therapeutics for Kimyrsa™
• Merck & Co. for Vaxneuvance™, Verquvo® and Welireg™
• Novartis for Kesimpta®, Leqvio®, Scemblix® and Tabrecta®
• Novo Nordisk for Sogroya® and Wegovy™
• NS Pharma for Viltepso®
• Otsuka Pharmaceutical for Inqovi®
• Oyster Point Pharma for Tyrvaya™
• Pfizer for Comirnaty®, Prevnar 20® and TicoVac™
• Pharmacosmos for Monoferric®
• Recordati Rare Diseases for Cystadrops® and Isturisa®
• Regeneron Pharmaceuticals for Evkeeza® and Inmazeb™
• RVL Pharmaceuticals for Upneeq®
• Sanofi for Fexinidazole, MenQuadfi™, Nexviazyme™ and Sarclisa®
• SCYNEXIS for Brexafemme®
• Seqirus for Audenz™
• Sunovion Pharmaceuticals for Kynmobi®
• Sun Pharmaceutical Industries for Winlevi®
• Taiho Oncology for Inqovi®
• TG Therapeutics for Ukoniq®
• UroGen Pharma for Jelmyto®
• ViiV Healthcare for Apretude, Cabenuva and Rukobia
• Y-mAbs Therapeutics for Danyelza®
8

Heart of BioNJ Awards
Presented to 2020 & 2021 New Jersey COVID-19 Heroes

• Dr. Andrew Brooks (posthumously): Led the Discovery of the First
COVID-19 Saliva-Based Test

• Dr. Brian Strom: New Jersey’s Go-to Expert and Epidemiologist in
Educating the Community and Leading the Fight Against COVID-19
at Rutgers University and Beyond

• Minister Mary Phillips-Blackshear: Pfizer COVID-19 Vaccine Clinical
Trial Participant

• Jean Walters: Janssen Johnson & Johnson COVID-19 Vaccine
Clinical Trial Participant

• Eli Lilly: Bamlanivimab & Etesevimab
• Fosun Pharma: COVID-19 RT-PCR Detection Kit
• Gilead: Veklury
• GSK: Sotrovimab
• Janssen Johnson & Johnson: JNJ-78436735 COVID-19 Vaccine
• Merck & Co.: Molnupiravir & Manufacturing COVID-19 Vaccines
• Novartis: Manufacturing COVID-19 Vaccines
• Pfizer: Comirnaty COVID-19 Vaccine & PAXLOVID™
• Princeton University: The Mechanical Ventilator Milano
• Rutgers, The State University of New Jersey: FIRST Saliva

COVID-19 Test
• Sanofi: Manufacturing COVID-19 Vaccines

INNOVATOR AWARDS PRESENTED BY:

Minister Mary Phillips-Blackshear Jean Walters

9

The Dr. Sol J. Barer Award for
Vision, Innovation and Leadership

Sol J. Barer, Ph.D.
Former Chairman and CEO
Celgene Corporation
Chairman of the Board
Teva Pharmaceutical Industries

Dr. Barer spent most of his professional career with
the Celgene Corporation. He was Chairman from
January 2011 until June 2011, Executive Chairman
from June 2010 until January 2011 and Chairman and
Chief Executive Officer from May 2006 until June 2010.
Previously he was appointed President in 1993 and
Chief Operating Officer in 1994 before assuming the
CEO position. He also served as Senior Vice President,
Science and Technology, and Vice President/General Manager, Chiral Products,
from October 1990 to October 1993, and Vice President, Technology, from
September 1987 to October 1990. Dr. Barer was the founder of the biotechnology
group at the Celanese Research Company which was subsequently spun out to
form Celgene.
Dr. Barer currently serves as Chairman of the Board of the public companies Teva
Pharmaceutical Industries and Neximmune and the private company Centrexion,
is a Director of 3D Biotherapeutics and Zephyr.ai, and is Lead Director of the
public company ContraFect. He is the Founding Chair of the HMH Center for
Discovery and Innovation. He is a Founder of MIG, an organization dedicated
to helping Israeli biotech entrepreneurs and is a Venture Advisor to the Israel
Biotechnology Fund as well as an advisor to biopharma companies.
In 2011, Dr. Barer was Chairman of the University of Medicine and Dentistry of
New Jersey Governor’s Advisory Committee which resulted in sweeping changes
in the structure of New Jersey’s medical schools and public research universities.
He previously served as a Commissioner of the NJ Commission on Science and
Technology. He was a member of the Board of Trustees of Rutgers University
(until 2013). He also served two terms as Chair of the Board of Trustees of BioNJ
(2010-2012). Dr. Barer was named to the “Worldview 100” (Scientific American’s
100 most influential figures in today’s world of biotechnology) in 2015, named one
of “25 Leadership Legends of NJ” (NJBIZ) in 2012, “The 50 Most Powerful People
in N.J. Health Care,” in 2012, inducted into the NJBIZ Hall of Fame in 2011 and was
named as one of NJ’s top 10 scientists by New Jersey Business in 2008. Dr. Barer
has received numerous professional awards. has received numerous professional
awards.
10

The 2022 Dr. Sol J. Barer Award for
Vision, Innovation and Leadership Recipient

Judith M. Persichilli, R.N., B.S.N., M.A.
Commissioner of Health
Merck & Co., Inc.
Judith M. Persichilli, R.N., B.S.N., M.A., began serving
as Commissioner of Health in August 2019.
She has been alongside Gov. Murphy leading the
state’s response to the COVID-19 pandemic. Along
with the response to this once-in-a century health
emergency, the Department of Health under her
leadership works to protect and improve the health
of New Jersey residents. The Department’s priorities
include reducing health disparities, improving
maternal health, addressing the overdose epidemic
and increasing access to health care.
Prior to leading the department, Ms. Persichilli served as the Acting Chief
Executive Officer (CEO) of University Hospital in Newark.
Ms. Persichilli was president emerita of CHE Trinity Health, the health ministry
formed in May 2013 by the consolidation of Catholic Health East and Trinity
Health of Livonia, MI. She previously served as the interim president and CEO of
CHE Trinity Health. Prior to this appointment, Ms. Persichilli was President and
CEO of Catholic Health East.
Ms. Persichilli joined CHE in 2003 as the Executive Vice President of the Mid-
Atlantic Division. She was promoted to Executive Vice President of acute care for
the system in 2008 and then to Executive Vice President and Chief Operating
Officer in December 2009 before assuming the role of CEO. Prior to joining
CHE’s System Office, she served for eight years as CEO at St. Francis Medical
Center in Trenton.
Ms. Persichilli received her nursing diploma from the St. Francis Hospital School
of Nursing, a Bachelor of Science in Nursing summa cum laude from Rutgers
University, and a Master of Arts in Administration summa cum laude from Rider
University.

11

Thank You to Our Upper Tier Members

MARKET MAKER
PREFERRED

EXECUTIVE

12

Because Patients Can’t Wait® BioNJ Members as of 5/25/2022

Innovation & Associate BioMarin Pharmaceutical Inc. Eli Lilly and Company
BIOTRIAL, Inc. Eloxx Pharmaceuticals, Inc.
A.J. O’Connor Associates Birch Benefits, LLC Emericlin
AbbVie Inc. Boehringer Ingelheim Animal Enalare Therapeutics Inc.
Adare Pharma Solutions Health USA Inc. Erica Ferry & Associates LLC
Adastra Pharmaceuticals, Inc. Bristol-Myers Squibb Company Evotec, Inc.
ADC Therapeutics Buchanan Ingersoll & Rooney PC Evrys Bio, LLC
Adiso Therapeutics, Inc. CAI - Commissioning Agents, Inc EY US LLP
ADMA Biologics, Inc. Caladrius Biosciences, Inc. Faegre Drinker Biddle & Reath
Admera Health CBIZ Insurance Services, Inc. Ferox Therapeutics
ADRA Change Architects CBRE Ferring Pharmaceuticals, Inc.
Advanced Accelerator Applications Cellares Corporation Fidelis Pharmaceuticals
Advaxis, Inc. Celldex Therapeutics, Inc. First Republic Bank
Agile Therapeutics, Inc. Celsion Corporation First Wave BioPharma,Inc.
Airgas East Celularity Inc. Fisher Scientific Company LLC
AIVC Centri Business Consulting Focus-X Therapeutics, Inc.
Amarin Pharma, Inc. CFGI Fosun Pharma USA Inc.
AMGEN Chemical and Pharmaceutical Friedman LLP
Amici Clinical Research LLC Solutions Gamida Cell
Amicus Therapeutics, Inc. Chromocell Corporation Geistlich Pharma North
Antios Therapeutics Chugai Pharma USA, Inc. America, Inc.
Apprentice.io Clinical Genomics Genentech
Ascelia Pharma CMIC CMO USA GENEWIZ, LLC
Ascendia Pharmaceuticals, LLC CohnReznick LLP Genmab
Ashton Tweed, LTD Conner Strong & Buckelew Gennao Bio
Assetive ConSynance Therapeutics Genomic Prediction Inc.
Atux Iskay Group LLC Controlled Contamination Services Gilead Sciences Inc.
Avotres Inc. Cornerstone Search Group, LLC Greenwich Biosciences
Ayma Therapeutics, Inc. Cresa Global Inc. GSG Scientific, LLC
AyurvedicDoc LLC Crowley Law LLC GSK
BalinBac Therapeutics, Inc. Crystal Pharmatech, Inc. Hart & Chin Associates, LLC
Bancroft Construction Company CSS Building Services, Inc. Hatch BioFund
Barer & Son Capital, LLC Cyclacel Pharmaceuticals, Inc. Helsinn Therapeutics, Inc.
Bayesian Biotech Deloitte Hepion Pharmaceutics Inc.
BDO USA, LLP Delphine Diagnostics Inc. Herspiegel Consulting LLC
Bezwada Biomedical, LLC Delve Therapeutics Hetero USA
BioAdvance DLA Piper LLP Hillstream BioPharma Inc.
BioAegis Therapeutics Inc. Duke Energy Sustainable Solutions Horizon Therapeutics
BioBridges DZS Clinical Services, Inc. HotSpot Therapeutics
BioEnsemble LLC Edenbridge Pharmaceuticals, LLC Hovione LLC
Biogen EisnerAmper Hurley Consulting Associates, Ltd.

13

Because Patients Can’t Wait® BioNJ Members as of 5/25/2022

IBM MetasTx, LLC PharmaNest Inc.
Incedo, Inc. MG Miller Intellectual Property Pharmatech Solutions LLC
Infinity Resources, LLC Law LLC Phathom Pharmaceuticals
Insmed Incorporated Mintz, Levin, Cohn, Ferris, Phio Pharmaceuticals Corp.
Insperity, Inc. Glovsky & Popeo, PC PMV Pharmaceuticals, Inc.
Integrated Project Management Mitsubishi Tanabe Pharma PNC Bank
Company, Inc. America, Inc. Porzio, Bromberg and Newman P.C.
Interius BioTherapeutics, Inc. MMR Consulting Inc. PR Newswire
Intrommune Therapeutics Modal Technology Corporation PricewaterhouseCoopers, LLP
Ipsen Modern Meadow Inc. Prima Innovations LLC
IVERIC bio Morgan Lewis Prosper Digital Therapeutics, Inc
J-STAR Research, Inc. Morgan Stanley PsychoGenics Inc.
Jackson Lewis P.C. MSL Pharma PTC Therapeutics, Inc.
Javan Engineering & Construction MSQ Ventures Inc. Radford/Aon
Jesra Advisors, LLC NAKI Therapeutics Rafael Pharmaceuticals, Inc.
JMS Pharma LLC NDA Group Recordati Rare Diseases
Johnson & Johnson (Janssen) Nevakar, Inc. Ricovr Healthcare Inc.
Jones Lang LaSalle Nexomics Biosciences, Inc. RSM US LLP
JPMorgan Chase Bank NA NJ Biopharmaceuticals LLC Sampled
Jubilant Therapeutics Inc. NJ Health Foundation Sanguine Biosciences
Kanvas Biosciences, Inc. NovaRock Biotherapeutics, Ltd. Sanofi
Katten Muchin Rosenman LLP Novartis Pharmaceuticals Science Branding
Kenox Pharmaceuticals, Inc. Corporation Communications
Korn Ferry International Novo Nordisk Scynexis, Inc.
Kyowa Kirin, Inc. Nucleus Network Sellas Life Sciences Group
Lactiga, Inc. Oncosec Medical Incorporated SHINKEI Therapeutics
Langan OncoSTING Signum Biosciences, Inc.
LeaderStrong Optinose Silence Therapeutics
Legend Biotech USA, Inc. Organon Silicon Valley Bank
LifeNet Health OrthogenRx, Inc. Simphotek Inc.
Lowenstein Sandler LLP OsseoPrint 3D Smirta Innovations Inc.
Mancino Burfield Edgerton Otsuka America Pharmaceutical, Inc. Soligenix, Inc.
Marsh Inc. Outlook Therapeutics, Inc. Sonder Research X
Matinas BioPharma Holdings, Inc. Ovid Therapeutics Sonnet BioTherapeutics, Inc.
MBrace Therapeutics, Inc. Oyster Point Pharma, Inc. Starton Therapeutics
McCarter & English LLP Palatin Technologies, Inc. StimBiotics Inc.
McKinsey & Company Panavance Therapeutics Inc. Stone Creek Construction
Medifvu, LLC Passage Bio Group LLC
Medix PendoTECH Strategies for Success Int’l
Melinta Therapeutics Pfizer Inc. Streetworks Development/
Mercer Health & Benefits LLC PhageNova Bio, Inc. Hudson Labs
Merck & Co., Inc. Pharmaceutical Advisors LLC Sweetwater Construction Corp.
Pharmacosmos Therapeutics
14

Because Patients Can’t Wait® BioNJ Members as of 5/25/2022

Tactical Therapeutics, Inc. Mid-Atlantic - Eurasia Advisory
Taiho Oncology, Inc. Business Council
Talking Medicines Limited Biotechnology Innovation
TAXIS Pharmaceuticals, Inc. Monmouth University Organization
TCG GreenChem, Inc. Princeton Public Affairs Group
Tech Council Ventures New Jersey Business & Industry
Teclison USA Limited Association International
TetherView
TEVA Pharmaceuticals New Jersey Economic Hikal Ltd.
Tevogen Bio Inc. Development Authority (NJEDA) Flanders Investment & Trade
The Cove JC
Toppan Merrill New Jersey Institute of
TrialSpark Technology (NJIT)
Tyme Inc.
Ulteemit BioConsulting, LLC New Jersey State Chamber
Urigen Pharmaceuticals, Inc. of Commerce
USI Insurance Services
VelocIT Office of Business Engagement,
Vertex Pharmaceuticals Middlesex County
Verve Group Consulting
Vifor Pharma PA Biotechnology Center
VOZ Advisors
Vyant Bio, Inc. Princeton Innovation
Vyome Therapeutics Inc. Center BioLabs
WhizAI
WithumSmith+Brown, PC Princeton Mercer
Woodfield Distribution, LLC Regional Chamber
Y-mAbs Therapeutics, Inc.
Princeton University

Rowan University

Rutgers, The State University
of New Jersey

Seton Hall Law School

Somerset County Business
Partnership

Students 2 Science, Inc.

TechUnited:NJ

UK Department for
International Trade

We Work For Health

Institution Patient Advocacy

Center for Healthcare Innovation, NJ Center for Tourette Syndrome
Stevens Institute of Technology and Associated Disorders Inc.
Choose New Jersey Professional Patient Advocates
Coriell Institute for Medical in Life Sciences
Research Project 8p
Drew University Sepsis Alliance
ExportJERSEY Susan G. Komen North Jersey
Hackensack University The Family Resource Network
Medical Center The Leukemia & Lymphoma Society
Institute for Life Science Thea’s Star of Hope
Entrepreneurship U.S. Pain Foundation
Kean University

15

BioNJ Salutes Our Sponsors

Sponsors as of 05/20/2022

16

The biotechnology industry is transforming
people’s lives in New Jersey and beyond.
BIO’s member companies develop
breakthroughs every day.
Biotechnology innovators are bringing
treatments and vaccines to cure patients
around the globe, creating sustainable fuels
to protect our climate, and developing
agricultural innovations to nourish humanity.
BIO. Where breakthroughs begin.

We’re inspired by a single vision:

We’re proud to support BioNJ.

Visit bms.com to see how we’re bringing a human touch to everything we do.

© 2022 Bristol-Myers Squibb Company. All rights reserved.

Making a

difference.

F O R O U R C L I E N T S A N D O U R C O M M U N I T Y.

PROUD TO SUPPORT NORCROSS

Bio NJ FOUNDATION

2022 Annual Dinner Meeting
& Innovation Celebration

George E. Norcross III, Executive Chairman
Joseph Buckelew, Chairman

Michael Tiagwad, President and Chief Executive Officer
Daniel Brettler, Senior Partner, National Life Science Practice Leader

connerstrong.com • 1-877-861-3220 INSURANCE | RISK MANAGEMENT | EMPLOYEE BENEFITS

When the human ©2022 Ernst & Young LLP. All Rights Reserved. 2202-3977174 | ED None.
body is the biggest
data platform, who
will capture value?

In this Transformative Age, technology is helping
reimagine industries in limitless ways.
ey.com/lifesciences #BetterQuestions

We are an international
biotech company committed
to improving the lives of
people with our differentiated
antibody medicines.

genmab.com

Working to transform the
future of cancer treatment

Transforming
Lives as a Team

As a steadfast supporter of BioNJ, Faegre Drinker shares your
commitment to innovation in the life sciences. We applaud
tonight’s award recipients and congratulate you all on another
year of improving the lives of patients and their families!

faegredrinker.com

© 2022 Faegre Drinker Biddle & Reath LLP.
All Rights Reserved.

Creating
Possible

Gilead is a proud supporter of
BioNJ's 2022 Annual Dinner
Meeting & Innovation Celebration.

For more information, please visit www.Gilead.com.



The image depicted contains models and is being used for Creating a future
illustrative purposes only. Janssen Biotech, Inc. © JB, Inc. 2022 where disease is a
thing of the past.

We are Janssen, the Pharmaceutical Companies of
Johnson & Johnson. Bold thinkers. Big dreamers.
Fearless advocates on behalf of patients. So that
one day, the world’s most daunting diseases will
be found only in the pages of history books.
Learn more at www.janssen.com.

HOW DOES THIS MEMBER
DRIVEN GROUP DELIVER HIGH

QUALITY DEAL FLOW?

In 2021, Keiretsu Mid-Atlantic and South-East members

1 invested over $13.1 M in 45 companies breaking the
investing level record for the second year in a row.

2 Members collaborate on rigorous Due Diligence, that on
average leads 70- 80% of the fully vetted deals to funding.

Keiretsu Forum’s investments are strengthened by extensive

3 educational opportunities, stimulating investing decisions

and long-lasting strategies.

Be our guest at a North Jersey Chapter meeting, held by

+ host sponsor Morgan Lewis in Princeton. Contact

Harvey Homan, at [email protected]

Marsh is a proud supporter of BioNJ.

Congratulations to all the 2022 award recipients.

At Marsh our purpose is Possibility. We seek better ways to manage risk
and human capital and define more effective paths to the right outcome.

Invent with us

Merck Business Development and Licensing

We invent because the world still needs
cures for cancer, Alzheimer’s disease, HIV,
and so many other causes of widespread
suffering.

Building strong partnerships is critical to
solving these challenging diseases – so
we can help people go on, unburdened, to
experience, create, and live their best lives.

Together we can invent more.
merck.com/licensing

Merck & Co., Inc., Kenilworth, New Jersey, USA is known as MSD outside of the United States and Canada.
Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. 05-22

The McNeilly Group L – Chris Connolly Elizabeth McNeilly, CFP ®
at Morgan Stanley C – Elizabeth McNeilly
R – Lauren Conigliaro Executive Director, Financial Advisor
is pleased to
celebrate BioNJ and Lauren Conigliaro
their community of
Portfolio Manager, Financial Planning
innovators in NJ. Specialist, Financial Advisor

Christopher Connolly

Portfolio Management Associate

Morgan Stanley Wealth Management © 2022 Morgan Stanley Smith Barney LLC. Member
120 Albany Street, 4th Floor SIPC. CRC 4672066
New Brunswick, NJ 08901
Phone: 732-435-2217

Email: [email protected]
Website: https://advisor.morganstanley.com/elizabeth.mcneilly

Certified Financial Planner Board of Standards, Inc. (CFP Board) owns the certification marks CFP®, CERTIFIED FINANCIAL
PLANNER™, and CFP® (with plaque design) in the United States, which it authorizes use of by individuals who successfully

complete CFP Board’s initial and ongoing certification requirements.

NJBIZ EVENT NOMINATIONS

NOMINATE NOW AT NJBIZ.COM/EVENTS

NOMINATION DEADLINE: 2022
JULY 3
MECHANICANLOMVINAETJIUONLNYDT3E1 AIDLLINAE:TOR MILANO

NOMINATION DEADLINE: In 2020, asNOMINATION DEADLINE: COVID-19 buckled healthcare system
SEPTEMBER 11 OCTmOBoErRe25than 250 particle physicists, engineers,
physicians and others from around the globe work
A program of together to meet the rocketing demand for de
assist breathing.

Nomination deadlines and event datesLpaehrdyesbicsysuC,btrhijseetyicatcnrteGoaatclebhdiaaatni,sgaimeP,prilnecmeteocnhapnroicfeasl svor of
visit njbiz.com/events fotrhdatectoauillsd. be mass produced using readily av

Questions? Contact [email protected]. • Forpsaprtso.nsorship opportunities,

contact Ken Kiczales at [email protected], Cristian and team, on you
“Heart of BioNJ Award”!

NJMEP – Helping Life
Science Manufacturers

Achieve Success

Consulting
—

Training
—

Accountability

Call today and speak with a Life Science Expert

NJMEP.org | [email protected] | (973) 998-9801 |

O
ms,
k

ur

Would like to
CONGRATULATE

THE HONORABLE

JUDITH M.
PERSICHILLI

on being awarded the
Dr. Sol J. Barer Award,
as well as the winners of
The Innovator Awards.

JUNE 2022:
31ST ANNUAL INNOVATIVE STATE EDITION

READ THE DIGITAL ISSUE NOW
NJBMAGAZINE.COM

PROUD MEDIA SPONSOR: BIONJ 2022 ANNUAL DINNER MEETING







Thinking about your
business is a big part of ours.

PUT OUR LIFE SCIENCES INSIGHTS TO WORK FOR YOU.
To make confident decisions about the future, you need a
different kind of advisor. One who starts by understanding
where you want to go and then brings the ideas and insights
of an experienced global team to help get you there.
Experience the power of being understood.
Experience RSM.
rsmus.com/lifesciences

Visit rsmus.com/aboutus for more information regarding RSM US LLP and RSM International.

Collaborative Making the human connection.

Patient-Centered

At Taiho Oncology, our mission is to improve the lives of patients with
cancer, their families, and their caregivers. Taiho continues to deliver
innovative products to the U.S. and global marketplace.

The oncology patient, and their support systems, are
at the center of our every activity.

Dynamic

© TAIHO ONCOLOGY, INC. All rights reserved. 05/2022 TOI-PM-US-0556 v1

TOI-PM-US-0556 Patient Alliance Ad Print 5.25x3.75_L01.indd 1 4/20/22 10:47 AM



TEVA
AD

INSIDE
BACK
COVER

FISHER
AD

BACK
COVER